Cargando…

The metabolic outcomes of growth hormone treatment in children are gender specific

OBJECTIVE: To evaluate the impact of gender on the clinical and metabolic parameters in prepubertal growth hormone deficiency (GHD) children at diagnosis and during GH treatment (GHT). DESIGN: The data of 105 prepubertal children (61 males, 44 females, mean age 6.8 ± 0.7 years) affected by idiopathi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciresi, Alessandro, Radellini, Stefano, Guarnotta, Valentina, Mineo, Maria Grazia, Giordano, Carla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063876/ https://www.ncbi.nlm.nih.gov/pubmed/29925523 http://dx.doi.org/10.1530/EC-18-0135

Ejemplares similares

More Favorable Metabolic Impact of Three-Times-Weekly versus Daily Growth Hormone Treatment in Naïve GH-Deficient Children
por: Ciresi, Alessandro, et al.
Publicado: (2017)

Glucose Metabolism in Children With Growth Hormone Deficiency
por: Ciresi, Alessandro, et al.
Publicado: (2018)

Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report
por: Ciresi, A., et al.
Publicado: (2018)

Dual-release hydrocortisone improves hepatic steatosis in patients with secondary adrenal insufficiency: a real-life study
por: Guarnotta, Valentina, et al.
Publicado: (2019)

Metabolic Profile in a Cohort of Young Sicilian Patients with Klinefelter's Syndrome: The Role of Irisin
por: Radellini, Stefano, et al.
Publicado: (2022)

Gender-specific soluble α-klotho levels as marker of GH deficiency in children: a case–control study
por: Guarnotta, V., et al.
Publicado: (2022)

Hepatic Steatosis Index in Acromegaly: Correlation with Insulin Resistance Regardless of the Disease Control
por: Ciresi, Alessandro, et al.
Publicado: (2018)

Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study
por: Ciresi, Alessandro, et al.
Publicado: (2017)

Author Correction: Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study
por: Ciresi, Alessandro, et al.
Publicado: (2018)

Correction to: One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus
por: Radellini, Stefano, et al.
Publicado: (2021)

One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus
por: Radellini, Stefano, et al.
Publicado: (2021)

Improved Cardiovascular and Cardiometabolic Risk in Patients With Type 1 Diabetes and Autoimmune Polyglandular Syndrome Switched From Glargine to Degludec Due to Hypoglycaemic Variability
por: Guarnotta, Valentina, et al.
Publicado: (2018)

Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: a retrospective analysis
por: Guarnotta, Valentina, et al.
Publicado: (2018)

The Daily Consumption of Cola Can Determine Hypocalcemia: A Case Report of Postsurgical Hypoparathyroidism-Related Hypocalcemia Refractory to Supplemental Therapy with High Doses of Oral Calcium
por: Guarnotta, Valentina, et al.
Publicado: (2017)

Diabetic foot ulcers: Retrospective comparative analysis from Sicily between two eras
por: Guarnotta, Valentina, et al.
Publicado: (2021)

Long-term outcomes of conventional and novel steroid replacement therapy on bone health in primary adrenal insufficiency
por: Guarnotta, Valentina, et al.
Publicado: (2022)

Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency
por: Guarnotta, V, et al.
Publicado: (2019)

Impact of Chemical Endocrine Disruptors and Hormone Modulators on the Endocrine System
por: Guarnotta, Valentina, et al.
Publicado: (2022)

Maternal-foetal complications in pregnancy: a retrospective comparison between type 1 and type 2 diabetes mellitus
por: Guarnotta, Valentina, et al.
Publicado: (2021)

Levothyroxine and insulin requirement in autoimmune polyglandular type 3 syndrome: a real-life study
por: Guarnotta, V., et al.
Publicado: (2020)

Myoinositol supplementation in the treatment of gestational diabetes mellitus: effects on glycaemic control and maternal-foetal outcomes
por: Guarnotta, Valentina, et al.
Publicado: (2022)

Nutritional Intervention in Cushing’s Disease: The Ketogenic Diet’s Effects on Metabolic Comorbidities and Adrenal Steroids
por: Guarnotta, Valentina, et al.
Publicado: (2023)

Practical therapeutic approach in the management of diabetes mellitus secondary to Cushing’s syndrome, acromegaly and neuroendocrine tumours
por: Guarnotta, Valentina, et al.
Publicado: (2023)

Diabetes Secondary to Acromegaly: Physiopathology, Clinical Features and Effects of Treatment
por: Ferraù, Francesco, et al.
Publicado: (2018)

Predictive factors of polycystic ovary syndrome in girls with precocious pubarche
por: Guarnotta, Valentina, et al.
Publicado: (2021)

Prediction of diabetes mellitus induced by steroid overtreatment in adrenal insufficiency
por: Guarnotta, Valentina, et al.
Publicado: (2022)

Very Low-Calorie Ketogenic Diet: A Potential Application in the Treatment of Hypercortisolism Comorbidities
por: Guarnotta, Valentina, et al.
Publicado: (2022)

Vitamin D Deficiency in Cushing’s Disease: Before and After Its Supplementation
por: Guarnotta, Valentina, et al.
Publicado: (2022)

Gender-specific associations of serum sex hormone-binding globulin with features of metabolic syndrome in children
por: Al-Daghri, Nasser M., et al.
Publicado: (2016)

Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease
por: Guarnotta, Valentina, et al.
Publicado: (2020)

Irisin: A Possible Marker of Adipose Tissue Dysfunction in Obesity
por: Tomasello, Laura, et al.
Publicado: (2023)

Incretin Response to Mixed Meal Challenge in Active Cushing’s Disease and after Pasireotide Therapy
por: Barbot, Mattia, et al.
Publicado: (2022)

Growth Hormone Stimulation Testing Patterns Contribute to Gender Disparities in Growth Hormone Treatment
por: Kamoun, Camilia, et al.
Publicado: (2021)

Gender Bias in U.S. Pediatric Growth Hormone Treatment
por: Grimberg, Adda, et al.
Publicado: (2015)

Growth hormone treatment in non-growth hormone-deficient children
por: Loche, Sandro, et al.
Publicado: (2014)

The medical treatment with pasireotide in Cushing’s disease: an Italian multicentre experience based on “real-world evidence”
por: Pivonello, Rosario, et al.
Publicado: (2019)

Gender-specific regulation of response to thyroid hormone in aging
por: Suzuki, Satoru, et al.
Publicado: (2012)

Gender-Specific Impact of Sex Hormones on the Immune System
por: Sciarra, Francesca, et al.
Publicado: (2023)

Hormones and not gender influences outcome in severe infection
por: Angstwurm, M, et al.
Publicado: (2001)

Gender specific association of parathyroid hormone and vitamin D with metabolic syndrome in population with preserved renal function
por: Kim, Min-Hee, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tbd4hao5b1ltbe9shr8d84ag2g